Patient Enrollment Marketing for Phase II Arthritis Drug

February 9, 2018

Challenge

Meet the one year enrollment timeline for this 216 patient study. When ThreeWire was engaged, total enrollment stood at only 70 patients after six months.

Solution

ThreeWire implemented media outreach in the US and Canada, as well as ThreeWire Chart Review services™ at selected sites in Europe, Canada and the US. Media patients were prescreened by our Patient Interaction Center® and referred to sites. Chart review candidates were contacted by telephone and/or letter for prescreening.

Results

Seventeen percent of media responses were referred to sites and more than 5% of referrals were randomized, yielding 45 enrollments. More than 800 candidates were identified during chart reviews, yielding 26 enrollments. ThreeWire produced 71 total randomizations and study enrollment was completed one month ahead of schedule.

Previous Flipbook
Patient Enrollment Marketing for Phase II Heart Failure Study
Patient Enrollment Marketing for Phase II Heart Failure Study

Jump-start enrollment in the US for this large international study so that early enrollment rates did not f...

Next Flipbook
Patient Enrollment Marketing for Phase II OAB Drug- Europe
Patient Enrollment Marketing for Phase II OAB Drug- Europe

Jump start enrollment at a small number of key sites in order to generate momentum for quickly enrolling th...